Nathan D. Jorgensen - Chief Financial Officer at Voyager Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
VYGR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nathan D. Jorgensen since 12/17/2023

Holdings reported by Nathan D. Jorgensen for Voyager Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 80K $790K $9.88 Oct 1, 2024 Direct
Stock Option (Right to Buy) 200K Jul 8, 2024 Direct Common Stock

Transactions reported by Nathan D. Jorgensen for Voyager Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.